Molecular diagnosis and outcome prediction in diffuse large B-cell lymphoma and other subtypes of lymphoma

Clinical Lymphoma
Karen DybkaerWing C Chan

Abstract

Lymphoid malignancies are grouped and characterized by their morphology, immunophenotype, and genetic aberrations to help establish a diagnosis. Use of microarray technology enables the simultaneous determination of expression levels for thousands of genes, providing an additional powerful tool for improving disease classification. In this review, recent studies of diffuse large B-cell lymphoma (DLBCL), primary mediastinal large B-cell lymphoma, mantle cell lymphoma (MCL), and follicular lymphoma are highlighted, and the impact of gene expression profiling on the molecular diagnosis of these diseases is discussed. Based on microarray-generated gene expression profiles, outcome predictors were constructed for DLBCL and MCL. Specific expression patterns of a limited number of genes at the time of diagnosis were linked to overall survival in DLBCL and MCL. Such predictors of prognosis may eventually lead to risk-adjusted treatment of lymphomas. Specific therapeutic targets may also emerge with increased insight into the molecular features of the different lymphomas, thus illustrating the usefulness of gene expression profiling not only to improve diagnosis and classification but also to generate prognostic indicators and targets f...Continue Reading

References

Oct 1, 1974·Cancer·R J Lukes, R D Collins
Nov 24, 1999·The New England Journal of Medicine·R KüppersK Rajewsky
Dec 22, 1999·Annals of Hematology·P Meusers, J Hense
Aug 24, 2000·Proceedings of the National Academy of Sciences of the United States of America·I S LossosR Levy
Apr 17, 2001·Histopathology·Y NozawaM Abe
Sep 14, 2001·Current Opinion in Oncology·B Coiffier
Jun 21, 2002·The New England Journal of Medicine·Andreas RosenwaldUNKNOWN Lymphoma/Leukemia Molecular Profiling Project
Jun 22, 2002·Proceedings of the National Academy of Sciences of the United States of America·Izidore S LossosRonald Levy
Feb 7, 2003·Proceedings of the National Academy of Sciences of the United States of America·Sean P BohenRonald Levy
Apr 17, 2003·Proceedings of the National Academy of Sciences of the United States of America·Nicole Y FangJoseph G Hacia
May 21, 2003·Proceedings of the National Academy of Sciences of the United States of America·Kojo S J Elenitoba-JohnsonMegan S Lim
Aug 6, 2003·Proceedings of the National Academy of Sciences of the United States of America·George WrightLouis M Staudt

❮ Previous
Next ❯

Citations

Mar 8, 2005·Drug Discovery Today·Travis DunckleyDietrich A Stephan
Sep 30, 2005·American Journal of Clinical Pathology·Juyuan GuoCharles W Caldwell
Mar 16, 2007·Blood·James O Armitage
Aug 7, 2009·Ocular Immunology and Inflammation·Sarah E CouplandJustine Smith
Mar 15, 2005·Clinical Nuclear Medicine·Veronica SolisRichard P Spencer
Dec 1, 2007·Advances in Anatomic Pathology·Bharat N NathwaniMilton R Drachenberg
Jun 7, 2005·Expert Review of Molecular Diagnostics·Kai FuWing C Chan
Jul 25, 2006·Annals of Saudi Medicine·Walid A MouradFouad Al Dayel
Aug 10, 2010·Molecular Cancer Research : MCR·Maria DiamandisGeorge M Yousef

❮ Previous
Next ❯

Related Concepts

Related Feeds

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

Related Papers

Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
In Sook WooHye-Kyung Ahn
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
Shu-Rui LiStephen A Bustin
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Russell D PettyGraeme I Murray
© 2022 Meta ULC. All rights reserved